351
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Mutations in the Antibiotic Target Genes Related to Clarithromycin, Metronidazole and Levofloxacin Resistance in Helicobacter pylori Strains from Children in China

, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & show all
Pages 311-322 | Published online: 30 Jan 2020

References

  • Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311–1315. doi:10.1016/s0140-6736(84)91816-66145023
  • McColl KE. Clinical practice. helicobacter pylori infection. N Engl J Med. 2010;362:1597–1604. doi:10.1056/NEJMcp100111020427808
  • Francois F, Blaser MJ. Improving helicobacter pylori eradication regimens. Ann Intern Med. 2006;144:140–141. doi:10.7326/0003-4819-144-2-200601170-0001316418415
  • Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev. 2000;22:283–297. doi:10.1093/oxfordjournals.epirev.a01804011218379
  • Xiang L, Zhu X, Huang D, Meng L, Wang L. Analysis on infection and drug resistance of helicobacter pylori in patients with gastric diseases. Chin J Nosocomiol. 2015;25:1710–1711.
  • Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of helicobacter pylori infection. MALT lymphoma study group. Lancet. 1995;345:1591–1594. doi:10.1016/s0140-6736(95)90113-27783535
  • Zhang YX, Zhou LY, Song ZQ, Zhang JZ, He LH, Ding Y. Primary antibiotic resistance of helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial study. World J Gastroenterol. 2015;21:2786–2792. doi:10.3748/wjg.v21.i9.278625759550
  • Shu X, Yin G, Liu M, Peng K, Zhao H, Jiang M. Antibiotics resistance of helicobacter pylori in children with upper gastrointestinal symptoms in Hangzhou, China. Helicobacter. 2018;23(3):e12481. doi:10.1111/hel.1248129528162
  • Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev. 2007;20:280–322. doi:10.1128/cmr.00033-0617428887
  • Megraud F, Benejat L, Ontsira Ngoyi EN, Lehours P. Molecular approaches to identify helicobacter pylori antimicrobial resistance. Gastroenterol Clin North Am. 2015;44:577–596. doi:10.1016/j.gtc.2015.05.00226314669
  • Thung I, Aramin H, Vavinskaya V, et al. Review article: the global emergence of helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016;43:514–533. doi:10.1111/apt.1362526694080
  • Matteo MJ, Perez CV, Domingo MR, Olmos M, Sanchez C, Catalano M. DNA sequence analysis of rdxA and frxA from paired metronidazole-sensitive and -resistant helicobacter pylori isolates obtained from patients with heteroresistance. Int J Antimicrob Agents. 2006;27:152–158. doi:10.1016/j.ijantimicag.2005.09.01916426819
  • Tu IF, Liao JH, Yang FL, Lin NT, Chan HL, Wu SH. Lon protease affects the RdxA nitroreductase activity and metronidazole susceptibility in helicobacter pylori. Helicobacter. 2014;19:356–366. doi:10.1111/hel.1214024834789
  • Lee JW, Kim N, Nam RH, et al. Mutations of helicobacter pylori associated with fluoroquinolone resistance in Korea. Helicobacter. 2011;16:301–310. doi:10.1111/j.1523-5378.2011.00840.x21762270
  • Garcia M, Raymond J, Garnier M, Cremniter J, Burucoa C. Distribution of spontaneous gyrA mutations in 97 fluoroquinolone-resistant helicobacter pylori isolates collected in France. Antimicrob Agents Chemother. 2012;56:550–551. doi:10.1128/aac.05243-1122064536
  • Rimbara E, Noguchi N, Kawai T, Sasatsu M. Fluoroquinolone resistance in helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in Gyr B. Helicobacter. 2012;17:36–42. doi:10.1111/j.1523-5378.2011.00912.x
  • Su P, Li Y, Li H, et al. Antibiotic resistance of helicobacter pylori isolated in the Southeast Coastal Region of China. Helicobacter. 2013;18:274–279. doi:10.1111/hel.1204623418857
  • Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement M100-S17. Wayne, PA, USA: CLSI; 2007.
  • Ribeiro ML, Vitiello L, Miranda MC, et al. Mutations in the 23S rRNA gene are associated with clarithromycin resistance in helicobacter pylori isolates in Brazil. Ann Clin Microbiol Antimicrob. 2003;2:11. doi:10.1186/1476-0711-2-1114633281
  • Marais A, Bilardi C, Cantet F, Mendz GL, Mégraud F. Characterization of the genes rdxA and frxA involved in metronidazole resistance in helicobacter pylori. Res Microbiol. 2003;154:137–144. doi:10.1016/s0923-2508(03)00030-512648728
  • Wang LH, Cheng H, Hu FL, Li J. Distribution of gyrA mutations in fluoroquinolone-resistant helicobacter pylori strains. World J Gastroenterol. 2010;16:2272–2277. doi:10.3748/wjg.v16.i18.227220458765
  • Chen J, Ye L, Jin L, et al. Application of next-generation sequencing to characterize novel mutations in clarithromycin-susceptible helicobacter pylori strains with A2143G of 23S rRNA gene. Ann Clin Microbiol Antimicrob. 2018;17:10. doi:10.1186/s12941-018-0259-829562911
  • Zhang J, Zhong J, Ding J, et al. Simultaneous detection of human CYP2C19 polymorphisms and antibiotic resistance of helicobacter pylori using a personalized diagnosis kit. J Glob Antimicrob Resist. 2018;13:174–179. doi:10.1016/j.jgar.2017.12.01829444465
  • Mahmoudi S, Mamishi S, Banar M, et al. Antibiotic susceptibility of helicobacter pylori strains isolated from Iranian children: high frequency of A2143G point mutation associated with clarithromycin resistance. J Glob Antimicrob Resist. 2017;10:131–135. doi:10.1016/j.jgar.2017.04.01128720314
  • Binkowska A, Biernat MM, Kaczmariski K, Gosciniak G. Molecular patterns of resistance among helicobacter pylori strains in South-Western Poland. Front Microbiol. 2018. doi:10.3389/fmicb.2018.03154
  • Quek C, Pham ST, Tran KT, et al. Antimicrobial susceptibility and clarithromycin resistance patterns of helicobacter pylori clinical isolates in Vietnam. F1000Research. 2016;5:671. doi:10.12688/f1000research.8239.127583131
  • Cagan-Appak Y, Gazi H, Ayhan S, Cengiz-Ozyurt B, Kurutepe S, Kasirga E. Clarithromycin resistance and 23S rRNA gene point mutations of helicobacter pylori infection in children. Turk J Pediatr. 2016;58:371–376. doi:10.24953/turkjped.2016.04.00428276208
  • De Francesco V, Margiotta M, Zullo A, et al. Clarithromycin-resistant genotypes and eradication of helicobacter pylori. Ann Intern Med. 2006;144:94–100. doi:10.1016/j.jpeds.2010.02.00716418408
  • Phan TN, Santona A, Tran VH, et al. High rate of levofloxacin resistance in h background of clarithromycin and metronidazole-resistant helicobacter pylori in vietnam. Inter J Antimicrob Agents. 2015;45:244–248. doi:10.1016/j.ijantimicag.2014.10.019
  • Jaka H, Rhee JA, Ostlundh L, et al. The magnitude of antibiotic resistance of helicobacter pylori in Africa and identified mutations which confer resistance to antibiotics: a systematic review and meta-analysis. BMC Infect Dis. 2018;18:193. doi:10.1186/s12879-018-3099-429699490
  • Ieradi E, Giorgio F, Lousurdo G, Di Leo A, Principi M. How antibiotic resistances could change helicobacter pylori treatment: A matter of geography? World J Gastroenterol. 2013;19:8168–8180. doi:10.3748/wjg.v19.i45.816824363506
  • Kim KS, Kang JO, Eun CS, Han DS, Choi TY. Mutations in the 23S rRNA gene of helicobacter pylori associated with clarithromycin resistance. J Korean Med Sci. 2002;17:599–603. doi:10.3346/jkms.2002.17.5.59912378008
  • Fock KM, Ang TL. Epidemiology of helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol. 2010;25:479–486. doi:10.1111/j.1440-1746.2009.06188.x20370726
  • Luo Z, Zhang S, Sun Z, et al. Study on relationship between drug resistance of helicobacter pylori to metronidazole and rdx A genotype and cagA gene. Chin Hosp Pharm J. 2015;35:689–694. doi:10.1016/j.jms.2008.06.014
  • Mirzaei N, Poursina F, Moghim S, Rahimi E, Safaei HG. The mutation of the rdxA gene in metronidazole-resistant helicobacter pylori clinical isolates. Adv Biomed Res. 2014;3:90. doi:10.4103/2277-9175.12846924761398
  • Tanih NF, Ndip LM, Ndip RN. Characterisation of the genes encoding resistance to metronidazole (rdxA and frxA) and clarithromycin (the 23S-rRNA genes) in South African isolates of helicobacter pylori. Ann Trop Med Parasitol. 2011;105:251–259. doi:10.1179/136485911X1289983868348521801504
  • Miyachi H, Miki I, Aoyama N, et al. Primary levofloxacin resistance and gyrA/B mutations among helicobacter pylori in Japan. Helicobacter. 2006;11:243–249. doi:10.1111/j.1523-5378.2006.00415.x16882327
  • Chisholm SA, Owen RJ. Frequency and molecular characteristics of ciprofloxacin-and rifampicin-resistant helicobacter pylori from gastric infections in the UK. J Med Microbiol. 2009;58:1322–1328. doi:10.1099/jmm.0.011270-019589906
  • Tankovic J, Lascols C, Sculo Q, Petit JC, Soussy CJ. Single and double mutations in gyrA but not in gyrB are associated with low-and high-level fluoroquinolone resistance in helicobacter pylori. Antimicrob Agents Chemother. 2003;47:3942–3944. doi:10.1128/AAC.47.12.3942-3944.200314638505
  • De Palma GZ, Mendiondo N, Wonaga A, et al. Occurrence of mutations in the antimicrobial target genes related to levofloxacin, clarithromycin, and amoxicillin resistance in helicobacter pylori isolates from Buenos Aires city. Microb Drug Resist. 2016;23:351–358. doi:10.1089/mdr.2015.036127391421
  • Miftahussurur M, Shrestha PK, Subsomwong P, Sharma RP, Yamaoka Y. Emerging helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal. BMC Microbiol. 2016;16:256. doi:10.1186/s12866-016-0873-627809767